Cargando…

Comparison of Treatment Efficacy and Survival Outcomes Between Asian and Western Patients With Unresectable Gastric or Gastro-Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis

BACKGROUND: Gastric cancer and gastro-esophageal adenocarcinoma are geographically heterogeneous diseases. Previous studies suggested that Asian and Western patients with late-stage gastric or gastro-esophageal adenocarcinoma possess distinct survival outcomes. However, the interregional differences...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhening, Liu, Zining, Chen, Zeyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936077/ https://www.ncbi.nlm.nih.gov/pubmed/35321436 http://dx.doi.org/10.3389/fonc.2022.831207

Ejemplares similares

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
por: Salati, Massimiliano, et al.
Publicado: (2022)

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials
por: Liang, Zhanpeng, et al.
Publicado: (2023)

Epstein–Barr Virus in Gastro-Esophageal Adenocarcinomas – Single Center Experiences in the Context of Current Literature
por: Genitsch, Vera, et al.
Publicado: (2015)

Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma
por: Davidson, Michael, et al.
Publicado: (2016)

OSeac: An Online Survival Analysis Tool for Esophageal Adenocarcinoma
por: Wang, Qiang, et al.
Publicado: (2020)

The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database
por: Amin, Saber, et al.
Publicado: (2020)

Editorial: Ano-rectal and gastro-esophageal cancer: diving into diagnostic and therapeutic imaging modalities for radiotherapy
por: Deantonio, Letizia, et al.
Publicado: (2023)

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
por: Svensson, Maria C., et al.
Publicado: (2019)

Spontaneous Regression of Metastatic Lesions of Adenocarcinoma of the Gastro-Esophageal Junction
por: Mitchell, Richard, et al.
Publicado: (2021)

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference
por: Mulder, Karen, et al.
Publicado: (2022)

Safety and efficacy of laparoscopic digestive tract nutrition reconstruction combined with conversion therapy for patients with unresectable and obstructive gastric cancer
por: Ye, Rong, et al.
Publicado: (2023)

Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas
por: Klein, Sebastian, et al.
Publicado: (2021)

Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma
por: Cai, Zhiyuan, et al.
Publicado: (2021)

Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas
por: Treese, Christoph, et al.
Publicado: (2016)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: A retrospective real-world study
por: Xiang, Xiaosong, et al.
Publicado: (2023)

Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients
por: Schumacher, Steven E., et al.
Publicado: (2017)

Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis
por: Creemers, A., et al.
Publicado: (2017)

Gastro-Esophageal Reflux in Children
por: Rybak, Anna, et al.
Publicado: (2017)

Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Xie, Tong, et al.
Publicado: (2021)

Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review
por: Di Girolamo, Elena, et al.
Publicado: (2023)

Gastric adenocarcinoma burden, trends and survival in Cali, Colombia: A retrospective cohort study
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2023)

Excellent response to oral Metronomic chemotherapy in unresectable adenocarcinoma of external auditory canal
por: Noronha, Vanita, et al.
Publicado: (2015)

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
por: Elliott, Jessie A., et al.
Publicado: (2021)

Esophageal adenocarcinoma with metastasis to the prostatic urethra and bladder
por: Olawoyin, Olamide M., et al.
Publicado: (2023)

Comparison of Efficacy of Self-Expandable Metallic Stent Placement in the Unresectable Esophageal Cancer Patients
por: Uesato, Masaya, et al.
Publicado: (2017)

Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma
por: Li, Xinge, et al.
Publicado: (2022)

Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer
por: Nishiofuku, Hideyuki, et al.
Publicado: (2015)

Construction and validation of a novel nomogram to predict cancer-specific survival in patients with gastric adenocarcinoma
por: Nie, Guole, et al.
Publicado: (2023)

Comparison of the Efficacy of D2 Gastrectomy Plus Liver Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone in the Treatment of Advanced Gastric Cancer With Unresectable Synchronous Liver Metastases: A Multicenter Randomized Controlled Trial Protocol
por: Wang, Weidong, et al.
Publicado: (2022)

Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma
por: Ochi, Masanori, et al.
Publicado: (2020)

S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
por: Li, Yuhong, et al.
Publicado: (2015)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy
por: Gao, Yiming, et al.
Publicado: (2022)

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Li, Weiwei, et al.
Publicado: (2022)

Involved-Field Radiation Therapy for Patients With Unresectable Pancreatic Adenocarcinomas: Failure Pattern Analysis
por: Fogaroli, Ricardo C, et al.
Publicado: (2023)

Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Wang, Jianing, et al.
Publicado: (2021)

Autophagic Heterogeneity in Gastric Adenocarcinoma
por: Yoon, Ju-Yoon, et al.
Publicado: (2021)

Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma
por: Thrift, Aaron P., et al.
Publicado: (2012)

Highlighting Survival with Yttrium-90 Radioembolization Therapy in Unresectable Hepatocellular Carcinoma
por: Nabrinsky, Edward, et al.
Publicado: (2020)

Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden
por: Asplund, Johannes, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dej87332jceo89m927gebhvpoe